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Abstract
Background/Aims: Myocardial reperfusion has the potential to salvage the ischemic 
myocardium after a period of coronary occlusion.  Reperfusion, however, can cause a wide 
spectrum of deleterious effects. Galectin-3 (GAL-3), a beta galactoside binding lectin, is closely 
associated with myocardial infarction (MI), myocardial fibrosis and heart failure.  In our study, 
we investigated its role in ischemia-reperfusion injuries (IR) as this phenomenon is extremely 
relevant to the early intervention after acute MI. Methods: C57B6/J wild type (WT) mice and 
GAL-3 knockout (KO) mice were used for murine model of IR injury in the heart where a 
period of 30 minutes ischemia was followed by 24 hours of reperfusion. Heart samples were 
processed for immunohistochemical and immunofluorescent labeling, morphometric analysis, 
western blot and enzyme-linked immunosorbent assay to identify the apoptotic, inflammatory 
and oxidative stress role of GAL-3. Results: Our results show that there was a significant 
increase in GAL-3 levels in the heart which shows GAL-3 is playing a role in the ischemia 
reperfusion injury.  Troponin I was also significantly higher in GAL-3-KO group than wild type. 
Our study shows that GAL-3 is associated with an increase in the antioxidant activity in the 
IR injured myocardium. Antioxidant enzymes superoxide dismutase, glutathione and catalase 
were found to be significantly raised in the GAL-3 wild type IR as compared to the GAL-3 KO IR 
group.   A significant increase in apoptotic activity is seen in GAL-3 KO IR group as compared 
with GAL-3 wild IR group. Conclusion: Our study shows that GAL-3 can affect the redox 
pathways, controlling cell survival and death, and plays a protective role on the myocardium 
following IR injury.
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Introduction
Early and successful myocardial reperfusion after an acute myocardial infarction (MI) is 
the most effective strategy for salvaging the myocardium and improving clinical outcomes. 
This process of restoring blood flow to the ischemic myocardium can, however, induce 
myocardial reperfusion injury and paradoxically reduce the beneficial effects of myocardial 
reperfusion. This injury results in the death of cardiac myocytes that were viable immediately 
before myocardial reperfusion [1], hence, despite prompt myocardial reperfusion, the rate of 
death after an acute MI approaches 9%, and the incidence of cardiac failure is almost 10% 
at 1 year [2, 3].
The concept of ischemia reperfusion (IR) injury was first introduced when scientists 
noticed that a large fraction of cellular enzymes were released not during hypoxia, but on 
sudden re-oxygenation [4].  This re-oxygenation of ischemic myocardium generates a degree 
of myocardial injury that exceeds injury induced by ischemia alone [4].  Timely reperfusion 
after MI can reduce the size of infarction up-to half, which means that reperfusion itself 
accounts for up-to 50% of final infarct size [5].  Reperfusion is also shown to affect a larger 
portion of the left ventricle than infarction alone, so IR injury may act as an independent 
determinant of cardiac remodeling [6].
IR injury is a combination of events that begins with oxidative stress, inflammation, 
intracellular Ca+ overload and subsequent progression into irreversible cell death by 
apoptosis and necrosis [7, 8]. Understanding the contribution of these processes to IR injury 
is essential to look for therapeutic measures that can help reduce the myocardial infarct size 
and cardiac remodeling; both crucial determinants of prognosis.
Galectin-3 (GAL-3) is  unique chimera-like galectin belonging to the family of lectins that 
specifically bind to N-acetyl-lactosamine-containing glycoproteins [9].  GAL-3 is expressed in 
a variety of cells, e.g., endothelial and epithelial cells, activated macrophages, microglial cells, 
basophils, mast cells, neutrophils, neurons and cardiomyocytes [10-16].  So far we know that 
GAL-3 is closely associated with myocardial infarction in the early post MI period and later 
with myocardial fibrosis and heart failure [15, 17]. Our aim is to further investigate if GAL-3 
has any role in IR injury of the myocardium.
The generation of reactive oxygen species (ROS) acts as central mediators of IR 
injury. These species can initiate spontaneous, and self-propagating radical reactions with 
biomolecules that impair myocardial function by activating intracellular proteolytic enzymes 
and induce cell death by initiating mitochondrial permeability transition [18, 19].  Most cells 
including cardiomyocytes contain enzymatic antioxidant defense mechanisms that quickly 
convert ROS to water. These antioxidant systems include superoxide dismutase, catalase, and 
the glutathione (GSH) redox system [20].  In addition to looking at the antioxidant enzyme 
activity in relation to GAL-3, we will look into the role of NRF2 (Nuclear factor-erythroid 2 
(NF-E2)-related factor 2) which is a redox-sensitive transcription factor that up-regulates 
cytoprotective and antioxidant genes expression to protect against IR injury.  During 
resting state, NRF2 is located in the cytoplasm sequestered with a cytoskeletal associated 
protein Keap 1 (Kelch-like ECH-associated protein 1). Keap 1 negatively regulates NRF2 by 
promoting its ubiquitination and proteosomal degradation.  When released from Keap 1, 
NRF2 translocate to the nucleus and binds as a heterodimer to the antioxidant response 
elements (ARE) located in the promoter region of genes encoding many antioxidant enzymes 
[21-24]. NRF2 thus controls GSH production and regeneration and its utilization among 
other antioxidant pathways [25]. Also in the myocardium, NRF2 is a critical element of redox 
homeostasis [26, 27].  Recently it has been demonstrated that in addition to protection 
against oxidative stresses NRF2 responds to pro-inflammatory stimuli and protects against 
inflammatory injuries and fibrosis [28-30].
We hypothesize that GAL-3 has a protective role on the myocardium during IR injury. 
We have used a murine model of myocardial ischemia-reperfusion injury with a period of 30 
min ischemia followed by 24 hours of reperfusion to investigate the protective role of GAL-3 
in IR injury through measuring myocardial inflammatory markers (IL-6, CRP, MPO, elastase), 
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cell death markers (Troponin I, cleaved caspase-3, cytochrome c, annexin V), cell survival 
marker (Bcl2) and anti-oxidant markers (GSH, catalase, SOD, NRF2, glutathione reductase, 
glutathione peroxidase).
Materials and Methods
Murine model of myocardial ischemia reperfusion injury
C57B6/J wild type (WT) (n=16) and GAL-3 knockout (KO) (The Jackson Laboratory, 006338, galactin3-, 
B6 Cg-Lgals3 <tm 1 Poi>/J HOM Homozygous genotype) (n=16) mice were used in this experiment.  All 
animals were male, aged 12-16 weeks and weighed 20-25 grams.  Sham operated animals (n=16) for each 
group were also studied.  In each group 8 hearts were collected for protein analysis while the other 8 hearts 
were collected for histological analysis.
All experimental animal procedures were approved by the Animals Ethics Committee of the College of 
Medicine and Health Sciences, UAE University.
Wild type and GAL-3 KO mice were anesthetized by an intraperitoneal injection of a combination of 
Ketamine (100mg/kg) and Xylazine (10mg/kg).  The mice were then intubated and connected to a mouse 
ventilator (Harvard apparatus Minivent Hugo Sachs Electronik) which supplied room air supplemented 
with 100 % oxygen (tidal volume 0.2 ml/min., rate 120 strokes/min). Body temperature was continuously 
monitored and maintained within 36-37°C. The lead II ECG (ADInstrument multi-channel recorder interfaced 
with a computer running Power lab 4/30 data acquisition software) was recorded from needle electrodes 
inserted subcutaneously.  Myocardial infarction was induced in the mice by permanently occluding the left 
anterior descending coronary artery (LAD) as described earlier [31-33].
Briefly, the chest was opened with a lateral incision at the 4th intercostal space on the left side of the 
sternum.  Next the chest wall was retracted for better visualization of the heart.  With minimal manipulation, 
the pericardial sac removed and the left anterior descending artery (LAD) visualized with a stereomicroscope 
(Zeiss STEMI SV8).  An 8-0 silk suture was passed under the LAD, a small 1 mm polyethylene tubing (PE) 
was placed on top of the LAD and the suture was ligated on the top of the PE tubing without damaging the 
artery.  Ischemia was confirmed by the pale discoloration of the left ventricle.  An accompanying ECG also 
showed corresponding ST- elevation.  After 30 minutes of ischemia the ligature is removed by cutting the 
knot on top of this PE tube. Reperfusion was confirmed visually and by ECG changes.
The chest wall was closed by approximating the third and fourth ribs with one or two interrupted 
sutures.  The muscles returned back to their original position and the skin closed with 4-0 prolene suture. 
The animal was gently disconnected from the ventilator and spontaneous breathing was seen immediately. 
Postoperative analgesic (Butorphanol 2mg/kg, s/c, 6 hourly) was given at the end of the procedure.  Sham 
operated mice underwent exactly the same procedure described above, except that the suture passed under 
the LAD is left open and untied.  According to the experimental protocol, mice were sacrificed 24 hours after 
induction of myocardial ischemia reperfusion.  The hearts were washed in ice cold PBS, right ventricle and 
both atria dissected away and left ventricle immediately frozen in liquid nitrogen and later stored in -80 °C 
freezer.  Blood was also collected in EDTA vacutainers and centrifuged at 3000 RPM for 15 minutes.  The 
plasma was collected, alliquoted and stored at -80 °C until further analysis. Heart samples from the same 
time point following LAD ligation were fixed in 10% buffered formal-saline for 24 hours.
Protein extraction from samples
Total protein was extracted from heart samples by homogenizing with lysis buffer and collecting the 
supernatant after centrifugation.  The Left ventricular (LV) heart samples were thawed, weighed and put in 
cold lysis buffer containing 50mM Tris, 300mM NaCl, 1mM MgCl2, 3mM EDTA, 20mM β-glycerophosphate, 
25mM NaF, 1% Triton X-100, 10%w/v Glycerol and protease inhibitor tablet (Roche Complete protease 
inhibitor cocktail tablets). The hearts were homogenized on ice by a homogenizer (IKA T25 Ultra Turrax). 
The samples were then centrifuged at 14000 RPM for 15 minutes at 4 °C, supernatant collected, alliquoted 
and stored at -80°C until further analysis.  Total protein concentration was determined by BCA protein assay 
method (Thermo Scientific Pierce BCA Protein Assay Kit).
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Immunohistochemistry
Hearts were excised, washed with ice-cold (PBS), blotted with filter paper and weighed. Each heart 
was sectioned into coronal slices of 2mm thickness then cassetted and fixed directly in 10% neutral 
formalin for 24 hours, which was followed by dehydration in increasing concentrations of ethanol, clearing 
with xylene and embedding with paraffin. Five-micrometer sections were prepared and mounted on 
aminopropyltriethoxysilane (APES) coated slides. After dewaxing with xylene and rehydrating with graded 
alcohol, slides were placed in a 0.01 M citrate buffer solution (pH=6.0) and pre-treatment procedures to 
unmask the antigens was performed in a water bath at 95°C for 30 minutes. Then, sections were treated with 
peroxidase block for 60 minutes followed by protein block for 60 minutes. Sections were incubated overnight 
with anti- GAL-3 antibody (rabbit anti-mouse polyclonal antibody 1:2500, Davids Biotechnologie GmbH, 
Germany) and anti-Catalase antibody (Rabbit Polyclonal, 1:400, Sigma, USA) at 4°C. While other sections 
were incubated with anti- cleaved caspase-3 antibody (Rabbit Polyclonal, 1:300, Cell signaling technology, 
USA), anti-cytochrome C antibody (Rabbit Polyclonal, 1:300, Cell signaling technology, USA),   anti-nuclear 
factor erythroid 2–related factor 2(NRF-2) antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-glutathione 
peroxidase antibody (Rabbit Polyclonal, 1:300, Abcam, USA), Anti- Superoxide dismutase (SOD) antibody 
(Rabbit Polyclonal, 1:300, Abcam, USA), anti-glutathione reductase antibody (Rabbit Polyclonal, 1:300, 
Abcam, USA), for one hour at room temperature. After conjugation with primary antibodies, sections were 
incubated with secondary antibody (EnVisionTM Detection System, DAKO, Agilent, USA) for 20 minutes at 
room temperature followed by addition of DAB chromogen (EnVisionTM Detection System, DAKO, Agilent, 
USA) and counter staining done with haematoxylin. Appropriate positive controls were used. For negative 
control, the primary antibody was not added to sections. Positive and negative controls were used in every 
batch of slides that were stained (not shown in figures).
Immunofluorescent labeling
Five-um sections were deparaffinised with xylene and rehydrated with graded alcohol. Sections were 
placed in EnVisionTM FLEX Target Retrieval Solution with a high PH (PH 9) (DAKO Agilent, USA) in a water 
bath at 95oC for 30 minutes hour.  Sections were washed with distilled water for 5 minutes followed by PBS 
for 5 minutes. Later they were incubated with anti-catalase (Rabbit Polyclonal, 1:100, Sigma, USA) antibody, 
anti-annexin-V antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-myeloperoxidase (MPO) antibody 
(Rabbit Polyclonal, 1:100, Abcam, USA), overnight at room temperature. Sections were subsequently 
incubated with donkey anti-rabbit Alexa Fluor 488, (Invitrogen, USA, 1:100) antibody. Finally, sections were 
mounted in water-soluble mounting media and viewed with Olympus Fluorescent microscope. Appropriate 
positive control sections were used. For negative control, the primary antibody was not added to sections 
and the whole procedure carried out in the same manner as mentioned above.
Morphometric analysis
Morphometric analysis of NRF2, SOD, glutathione reductase, glutathione peroxidase, catalase, 
cytochrome c, cleaved caspase-3 and annexin V expression in left ventricular cells was done at 24h 
following ischemia reperfusion using ImageJ software (http://rsbweb.nih.gov/ij/). NRF2, SOD, glutathione 
reductase, glutathione peroxidase, catalase, cytochrome c, cleaved caspase-3 and annexin v labeling were 
determined by counting the number of positive cells in randomly-selected high power fields (HPF) in the 
left ventricle.  The mean numbers of positive cells will be converted from per HPF to per mm2 (Each mm2 
= 4HPF). For NRF2 labeling, cells were considered positive when there was a nuclear staining pattern. For 
SOD, glutathione reductase, glutathione peroxidase, catalase, cytochrome c, cleaved caspase-3 labeling, cells 
were considered positive when there was a cytoplasmic staining pattern. For annexin V labeling, cells were 
considered positive when there was a membranous/cytoplasmic staining patterns.
Western blotting
Total protein extracts (50 ug) from each sample were resolved by SDSPAGE on 12.5% and 15% 
polyacrylamide gels depending on the molecular weight of the protein. The protein on gels was 
electrotransferred onto a Polyvinylidene difluoride (PVDF) membrane using Bio-Rad tank transfer system. 
The membranes were blocked in 5% non-fat dry milk solution in TBST for one hour at room temperature. 
The membranes were subsequently incubated overnight with primary antibodies anti- cleaved caspase-3 
(Rabbit Polyclonal, 1:1000, Cell signaling technology, USA), anti-cytochrome C (Rabbit Polyclonal, 1:1000, 
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Cell signaling technology, USA), anti BAX (Rabbit Polyclonal, 1:1000, Abcam, USA), anti-BCL2 (Rabbit 
Polyclonal, 1:1000, Abcam, USA), diluted in blocking buffer with gentle shaking at 4°C overnight. Membranes 
were also incubated overnight 4°C for Beta-actin antibody Rabbit Polyclonal, 1:1000, Cell signaling 
technology, USA),   diluted in TBST to control for equal loading. Blots were then incubated with horseradish 
peroxidase-conjugated secondary antibodies (rabbit anti-mouse Thermo-Pierce) and developed using ECL 
plus substrate (Thermo Pierce). Protein bands were visualized by a laser scanner (Typhoon FLA 9500, GE 
Healthcare Bio-Sciences AB, Sweden). Densitometric analysis of the protein bands was analyzed using image 
J software (https://imagej.nih.gov/ij/), NIH, USA. The blot intensities were normalized with that of β-actin 
as loading control.
Enzyme linked immunosorbent assay
Left ventricular myocardial concentration of GAL-3, c-reactive protein (CRP), neutrophil elastase, 
myeloperoxidase (MPO), interleukin-6 (IL-6), and cleaved caspase-3 were determined using DuoSet enzyme 
linked immunosorbent assay (ELISA) development kits [mouse galectin-3 (DY1197), mouse CRP (DY1829), 
mouse neutrophil elastase (DY4517), mouse MPO (DY 3667), mouse IL-6 (DY 406) and mouse cleaved 
caspase-3 (DYC 835), R&D Systems, Minneapolis, MN, USA] for sandwich ELISA, using standard procedure 
according to the manufacturer’s instructions. The levels were normalized to total protein concentrations. 
Briefly, 96-well plates Nunc-Immuno Plate MaxiSorp Surface (NUNC Brand Products, A/S, Roskilde, 
Denmark), were coated with antibody specific our proteins of interest. Biotinylated detection antibody and 
streptavidin conjugated horseradish peroxidase were used for detection of captured antigens. The plates 
between steps were aspirated and washed 3 times using ELISA plate washer (BioTek ELx50).  Captured 
proteins were visualized using tetramethylbenzidine (TMB)/hydrogen peroxide. Absorbance readings were 
made at 450 nm, using a 96-well plate spectrophotometer (BioTek ELx800).  Concentrations in the samples 
were determined by interpolation from a standard curve. Standards and samples were assayed in duplicate.
Glutathione and Catalase activity assay
Total glutathione level in the heart protein extract was measured by a glutathione (GSH) Assay kit 
(CS0260 Sigma-Aldrich).  Glutathione standard solutions were used to generate a standard curve and GSH 
levels calculated using Megallan6 software. Catalase activity was measured using Cayman Catalase assay kit 
(707002, Cayman USA).
Troponin-I Assay
Mouse cardiac troponin I levels in plasma were measured by using a high sensitivity mouse cardiac 
Troponin-I Elisa kit (2010-1-HSP, Life Diagnostics, Inc.) according to the manufacturer’s instructions.
Statistical analysis
All statistical analyses were done using GraphPad Prism Software version 5. Comparisons between 
the various groups were achieved by one-way analysis of variance (ANOVA), followed by Newman-Keuls 
multiple range tests. Data are presented in mean ± standard error (S.E). P values < 0.05 are considered 
significant.
Results
GAL-3 is increased after Ischemia-reperfusion injury in the heart
GAL-3 levels were significantly higher in the LV of GAL-3 wild type mice at 30 min 
ischemia and 24-hour post reperfusion time point as compared to sham operated mice 
(7862 ± 768.8 vs 4785 ± 273.5 pg/mg, P<0.001) as measured by ELISA (Fig. 1A). Our 
immunohistochemistry results also show significantly increased expression of GAL-3 in the 
heart section of IR group (Fig. 1B, D) as compared to sham-operated animals (Fig. 1C, E).
Cell Physiol Biochem 2018;50:1123-1139
DOI: 10.1159/000494539
Published online: 24 October 2018 1128
Cellular Physiology 
and Biochemistry
© 2018 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Al-Salam et al.: Role of Galectin-3 in Myocardial Ischemia Reperfusion Injury
GAL-3 is associated with increased inflammatory response following Ischemia-reperfusion 
injury in the heart
IL-6 levels in the LV of the IR GAL-3 wild group were significantly raised as compared to 
the IR GAL-3-KO group (61.22 ± 7.144 vs 44.45 ± 2.034 pg/ml, P<0.05) (Fig. 2A). CRP levels 
in the LV of the IR GAL-3 wild group were significantly raised as compared to the IR GAL-
3-KO group (86010 ± 7918 vs 21470 ± 545.3.6 pg/ml, P<0.001) (Fig. 2B). Neutrophil MPO 
Fig. 1. A. The graph 
represents left 
ventricular GAL-3 
concentrations in the 
wild type C57BL6 
IR group and GAL-
3 KO IR group with 
their corresponding 
shams. Data are 
shown as means 




low power view of 
heart sections showing GAL-3 expression in IR group (B) as compared to Sham operated control group 
(C).   Expression is seen as more intense staining in the LV area supplied by LAD (arrow heads) as well as 
right ventricular wall (thin arrow) (B). D&E show high power view of IR (D) and sham heart sections (E) 
expressing GAL-3 in the cytoplasm of cardiomyocytes (arrow head) and nuclei (thin arrow), endothelial 
cells (thick arrow) and neutrophil polymorphs (curved arrow) (D). The intensity and number of positive 




















Fig. 2. A. The graph 
represents left ventricular 
IL6 concentrations in the 
wild type C57BL6 IR group 
and GAL-3 KO IR group 
with their corresponding 
shams. B. The graph 
represents left ventricular 
CRP concentrations in the 
wild type C57BL6 IR group 
and GAL-3 KO IR group 
with their corresponding 
shams. C. The graph 
represents left ventricular 
MPO concentrations in the 
wild type C57BL6 IR group 
and GAL-3 KO IR group 
with their corresponding 
shams. D. The graph 
represents left ventricular 
elastase concentrations 
in the wild type C57BL6 
IR group and GAL-3 
KO IR group with their 
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levels in the LV of the IR GAL-3 wild group were significantly raised as compared to IR GAL-3-
KO group (358700 ± 20320 vs 293900 ± 19070pg/ml, P<0.01) (Fig. 2C). Neutrophil elastase 
levels in the LV of the IR GAL-3 wild group were significantly raised as compared to the IR 
GAL-3-KO group (16740 ± 1802 vs 9735 ± 1643 pg/ml, P<0.01)(Fig. 2D). Immunofluorescent 
staining of the heart section with MPO showed a comparatively higher number of neutrophil 
polymorphs in the IR GAL-3 wild group than IR GAL-3-KO group (Fig. 3).
GAL-3 has an anti-oxidant effect in IR injury
To assess the effect of GAL-3 on the oxidative stress we measured the status of the 
antioxidant enzymes total glutathione and catalase in the LV tissue protein extract in 
the GAL-3 wild type IR group and GAL-3 KO IR group.  Total glutathione levels were 
significantly raised in the GAL-3 wild type IR group (Fig. 4A) compared to the GAL-3 KO IR 
group (5.083 ± 0.6114 vs 2.707 ± 0.296 nmol/ mg protein, P<0.001). Total catalase levels 
were significantly raised in the GAL-3 wild type IR group (Fig. 4B) compared to the GAL-
3 KO IR group (183.3 ± 4.032vs 19.90 ± 1.131 nmol/min/ml, P<0.0001).  Morphometric 
analysis of immunohistochemically stained sections of the LV show a significantly higher 
number of cells showing nuclear expression of NRF2 in GAL-3 wild IR group than in GAL-
3 KO group (90.63 ± 9.517 vs 59.38 ± 8.898, P< 0.05) (Fig. 5 A-C). Morphometric analysis 
of immunohistochemically stained sections of the LV show a significantly higher number 
of cells showing cytoplasmic expression of SOD (61.63 ± 3.973 vs 50.13 ± 2.936, P< 0.05, 
Fig.  5D-F), and Glutathione reductase (43.00 ± 2.872 vs 32.50 ± 3.391, P< 0.01, Fig. 5G-I) 
Fig. 3. A&B. Representative 
sections of the left ventricle of 
IR group showing neutrophil 
polymorphs expressing MPO 
and infiltrating the myocardium 
(thin arrow). C&D. Representative 
sections of the left ventricle 
of IR-KO group showing a 
comparatively lower number 
of neutrophil polymorphs with 
similar expression of MPO, when 
compared to the IR group, and 
infiltrating the myocardium (thin 













Fig. 4. The graphs represent 
(A) left ventricular total GSH 
concentrations in the wild 
type C57BL6 IR group and 
GAL-3 KO IR group. (B) Left 
ventricular catalase activity 
in the wild type C57BL6 IR 
group and GAL-3 KO IR group. 
Data are shown as means ± 
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Fig. 5. Representative section of left ventricle (LV) showing nuclear expression of NRF2 by cardiac myocytes 
(thin arrow) and endothelial cells (arrow head) in IR GAL-3 wild mice (A) and IR GAL-3 KO mice (B). C. The 
graph represents morphometric analysis of NRF2 positive cells in GAL-3 wild IR & GAL-3 KO IR groups as 
compared to their sham controls.   Representative section of LV showing cytoplasmic expression of SOD by 
cardiac myocytes (thin arrow) in IR GAL-3 wild mice (D) and IR GAL-3 KO mice (E). F. The graph represents 
morphometric analysis of SOD positive cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their 
sham controls.   Representative section of LV showing cytoplasmic expression of glutathione reductase 
by neutrophil polymorphs (thin arrow) and endothelial cells (arrow head) in IR GAL-3 wild mice (G) and 
IR GAL-3 KO mice (H). I, The graph represents morphometric analysis of glutathione reductase positive 
cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. Representative section 
of LV showing cytoplasmic expression of glutathione peroxidase by neutrophil polymorphs (thin arrow), 
endothelial cells (arrow head) and cardiac myocytes (thick arrow) in IR GAL-3 wild mice (J) and IR GAL-
3 KO mice (K). L. The graph represents morphometric analysis of glutathione peroxidase positive cells in 
GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls.   Data are shown as means ± SEM. 
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Fig. 6. A&B represent a low power 
view of heart sections showing a 
significantly increased expression 
of catalase (thin arrows) in the 
area supplied by the LAD in 
GAL-3 wild type IR group (A) 
as compared to the GAL-3 KO 
IR (B) group, Alexa Fluor 488 
immunofluorescent labeling. 
C&D represent high power 
view of heart section showing 
cardiomyocytes (thin arrows) and 
inflammatory cells (arrow heads) 
expressing catalase in GAL-3 wild 
type IR group (C).  GAL-3KO IR 
group (D) shows comparatively 
fewer cardiomyocytes expressing 
catalase and mainly expressed 
by inflammatory cells (arrow 
heads), Alexa Fluor 488 
immunofluorescent labeling. 
E, shows a high power view 
of GAL-3 wild type IR group 
showing catalase expression by 
cardiomyocytes (arrow heads), 
inflammatory cells (thin arrows). 
Some neutrophil polymorphs 
are surrounding a dead 
cardiomyocyte (thick arrow). 
F, represents a corresponding 
high power view of heart section 
from the GAL-3 KO IR group 
with visibly lower catalase 
expression in cardiomyocytes 
(thick arrow) and mainly 
expressed by inflammatory cells 
(arrow heads). Alexa Fluor 488 
immunofluorescent labeling. G&I 
show the low and high power view 
of the heart section of the GAL-
3 wild type IR group expressing 
catalase as a cytoplasmic staining 
of cardiomyocytes (arrow head) 
and endothelial cells (thick 
arrow). Streptavidin- biotin 
immunoperoxidase method. H&K 
represent low and high power views of the GAL-3 KO IR group showing a comparatively lower expression 
of catalase by cardiomyocytes (arrow head). Streptavidin- biotin immunoperoxidase method. J. The graph 
represents morphometric analysis of catalase positive cells in GAL-3 wild IR & GAL-3 KO IR groups as 
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in GAL-3 wild IR group than in GAL-3 KO group, while there was no significant difference in 
the expression of glutathione peroxidase between GAL-3 wild IR group and GAL-3 KO group 
(40.38 ± 3.433 vs 37.63 ± 2.605, p= 0.5336, Fig. 5J-L).
Morphometric analysis of immunohistochemically stained sections of LV show a higher 
number of cells showing cytoplasmic expression of catalase in GAL-3 wild IR group than in 
GAL-3 KO group (74.38 ± 2.507 vs 43.50 ± 4.516, P< 0.001, Fig. 6J).
GAL-3 has an antiapoptotic effect in IR injury
Heart LV cleaved caspase-3 levels were significantly increased in the IR KO group as 
compared to the IR group (2367 ± 125.0 N=8 vs 2027 ± 93.47 pg/mg protein. P<0.05) using 
ELISA technique.
The relative heart LV cleaved caspase-3, cytochrome C, and BAX proteins expressions 
normalized to beta actin by western blot technique were significantly increased in IR KO 
group as compared to the IR group (0.4758 ± 0.01614 vs 0.1938 ± 0.01097 P<001), (0.6079 
± 0.02013 vs 0.3152 ± 0.02035 P <001), and (1.137 ± 0.04690 vs 0.8375 ± 0.02711 P <001) 
respectively, (Fig. 7). While the relative heart LV BCL2 protein expression normalized to beta 
actin by western blot technique was significantly higher in IR group as compared to the IR 
KO group (2.523 ± 0.04012 vs 1.067 ± 0.04912 P<0.001), (Fig. 7).
Fig. 7. A, Western blot 
analysis of cleaved 
caspase-3, cytochrome 
C, BAX, BCL2 and 
beta actin proteins in 
GAL-3 wild IR & GAL-
3 KO IR groups as 
compared to their sham 
controls. B, Graphical 
r e p r e s e n t a t i o n 
of densitometry 
analysis of cleaved 
caspase-3 protein band 
normalized to beta actin 
band in GAL-3 wild IR & 
GAL-3 KO IR groups as 
compared to their sham 
controls. C. Graphical 
representation of 
densitometry analysis 
of cytochrome C protein 
band normalized to 
beta actin band in 
GAL-3 wild IR & GAL-
3 KO IR groups as 
compared to their sham 
controls. D. Graphical 
representation of 
densitometry analysis 
of BAX protein band 
normalized to beta 
actin band in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. E. Graphical 
representation of densitometry analysis of BCL2 protein band normalized to beta actin band in GAL-3 wild 
IR & GAL-3 KO IR groups as compared to their sham controls.  Data are shown as means ± SEM. Statistical 
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Morphometric analysis of immunohistochemically stained sections of the LV show a 
significantly higher number of cells showing  cytoplasmic expression of cytochrome C in 
GAL-3 KO IR group than in GAL-3 IR wild group (76.50 ± 7.459 vs 53.75 ± 4.317, P< 0.01, Fig. 
8A-C)  Morphometric analysis of immunohistochemically stained sections of the LV show a 
significantly higher number of apoptotic cells stained with cleaved caspase-3 in GAL-3 KO IR 
group than in GAL-3 wild IR  group (14.00 ± 2.268 vs 7.625 ± 1.558 vs, P< 0.01, Fig. 8D-F).
Morphometric analysis of immunohistochemically stained sections of the LV show a 
significantly higher number of apoptotic cells stained with annexin V in GAL-3 KO IR group 
than in GAL-3 wild IR group (18.63 ± 2.897 vs 11.13 ± 1.807, P< 0.01, Fig. 8G-I)
Fig. 8. Representative section from the left ventricle (LV) showing cytoplasmic expression of cytochrome C 
in cardiac myocytes (thin arrow) in IR group (A) and IR-KO group (B). C, The graph represents morphometric 
analysis of cytochrome C positive cells in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham 
controls. Data are shown as means ± SEM. Statistical significance is expressed P<0.05. Representative 
section from the LV of the showing apoptotic cell expressing cleaved caspase -3 (thin arrow) in IR group 
(D) and IR-KO group (E). F. The graph represents morphometric analysis of cleaved caspase-3 positive cells 
in GAL-3 wild IR & GAL-3 KO IR groups as compared to their sham controls. Data are shown as means ± 
SEM. Statistical significance is expressed P<0.05. Representative section from the LV showing apoptotic cell 
expressing Annexin v on the cell membrane (thin arrow) in IR group (G) and IR-KO group (H) (Alexa Fluor 
488). I, the graph represents morphometric analysis of annexin V positive cells in GAL-3 wild IR & GAL-3 
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Total Troponin I in IR injury
Plasma Troponin I levels were significantly 
increased in the IR KO group as compared to the IR 
group (8.96931± 1.3845vs 3.727 ± 1.168 pg/mg protein 
P<0.001) (Fig. 9).
Discussion
Myocardial infarction is the leading cause of 
death in cardiovascular diseases worldwide. The 
magnitude of myocardial injury relates directly to the 
degree of reduction of blood flow and to the duration 
of the ischemic insult, which affects the levels to which 
cellular ATP and intracellular pH are reduced. The 
impairment of ATPase-dependent ion transport during 
ischemic insult causes intracellular and mitochondrial 
calcium levels to increase. At the same time cell volume 
regulatory mechanisms are disturbed due to the lack of 
ATP, which can induce disintegration of micro organelles 
and plasma membranes [8, 34].  Reperfusion, although required to rescue ischemic tissues, 
produces contradictory tissue responses that stimulate the production of reactive oxygen 
species, cause sequestration of proinflammatory cells in ischemic tissues, endoplasmic 
reticulum stress, and development of post ischemic capillary no-reflow, which amplifies 
tissue injury. These pathologic events terminate in opening of mitochondrial permeability 
transition pores as an end result of IR-induced cell death [1, 5, 35].
Blumgart et al. [36] reported that extensive infarction occurred when coronary occlusion 
was maintained for 40 minutes or longer, while occlusions of 5–20 minutes did not result in 
infarction. With occlusions of intermediate duration, the extent of necrosis depended on the 
time to reperfusion [37].  In our project we induced myocardial ischemia for 30 minutes 
followed by 24 hours reperfusion creating an environment where ischemic damage is 
limited to a time when irreversible damage starts to occur and 24 hour of reperfusion time 
gives adequate time for reperfusion related changes to take place.
Our aim in this study is to look at an acute time point after IR to see if GAL-3 plays any 
significant protective role at this early stage.
Our results show a significant increase in GAL-3 levels in the heart LV after IR injury as 
compared to sham-operated mice signifying that GAL-3 has some roles at this acute stage 
after IR.  Troponin I, a marker of cardiomyocytes injury, is also significantly higher in GAL-3-
KO group than GAL-3 wild group. In addition, proapoptotic proteins such as cleaved caspase 
3, cytochrome c and annexin V are significantly higher in GAL-3-KO group than GAL-3 wild 
group, while BCL2, an antiapoptotic protein, is significantly higher in GAL-3 wild group than 
GAL-3-KO group, supporting the notion that the raised GAL-3 post IR injury may in some way 
play a protective role (at least at the tested time point) in response to injury. Literature has 
many reports regarding anti-apoptotic role of GAL-3. GAL-3 has been shown to translocate 
either from the cytosol or from the nucleus to the mitochondria following exposure to 
apoptotic stimuli and blocks changes in the mitochondrial membrane potential, thereby 
preventing apoptosis [38]. GAL-3 has also been shown to translocate to the perinuclear 
membranes and inhibit cytochrome c release from the mitochondria and thereby inhibiting 
apoptosis [39]. GAL-3 can inhibit TNF- induced apoptosis through activation of AKT [40]. 
These anti-apoptotic effects of GAL-3 is further supported by the fact that overexpression of 
GAL-3 protects cell damage and death by motivating mitochondrial homeostasis [41].
The antioxidants glutathione and catalase levels are also significantly increased in the 
GAL-3 wild group as compared with the GAL-3 KO group. This shows that GAL-3 is associated 
with an increase in the antioxidant activity in the IR injured myocardium. The morphometric 
Fig. 9. The graphs represent plasma 
troponin I concentrations in the wild 
type C57BL6 IR group and GAL-3 KO 
IR group.  Data are shown as means 
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analysis of immunohistochemically-stained sections also shows higher expression of NRF2, 
SOD, GSH reductase, and catalase in GAL-3 wild group than in GAL-3 KO group which also 
supports antioxidant role of GAL-3. This is another evidence supporting the protective role 
of GAL-3 at 24-hour following IR injury.
SOD, glutathione and catalase are the most important cellular defense mechanism 
against oxidative injury and are the major intracellular redox buffer in ubiquitous cell types 
[42, 43]. Accumulating evidence suggests that the intracellular redox status regulates various 
aspects of cellular function [43]. Glutathione and catalase specifically provide significant 
antioxidant protection to the myocardium against IR injury [44-47]. Experiments using 
isolated heart models in the presence or absence of superoxide dismutase also showed ROS 
as likely mediators of reperfusion injury [48, 49].
Studies have shown that GAL-3 actions with regards to oxidative stress are variable; 
some point to its role as an inducer of ROS, but other studies explain its role as a molecule 
that is protective against ROS mediated injuries.  In an ischemia reperfusion model in kidney 
it was shown that ROS production was more prominent in GAL-3 wild type mice as compared 
to GAL-3 knockout mice [50]. Early data have also demonstrated that GAL-3 could stimulate 
superoxide production by neutrophils [51] and by monocytes [52]. So the presence of GAL-3 
produces more ROS and more antioxidant proteins.
In our study we found higher anti-oxidant activity in the LV myocardium after IR in 
conjunction with less myocardial damage in GAL-3 wild group than GAL-3 KO group. There 
can be many explanations for this phenomenon. The function of antioxidant systems is to 
modify the highly reactive oxygen species to form intermediates, which no longer pose a 
threat to the cell. A balance is essential between oxidation and antioxidant’s level in the 
system for healthy biological integrity to be maintained.  In previous studies, ischemia and 
reperfusion impaired superoxide dismutase activity and decreased cellular glutathione-to-
glutathione disulfide ratio suggested that the extent of superoxide anion radical produced 
at reperfusion exceeded the capacity of endogenous cellular antioxidant systems [53].  But 
the same oxidative stress can lead to increase in the antioxidant capacity and so the increase 
we see in the antioxidant enzymes may be due to the increase in the oxidative stress.  This 
phenomenon was observed in a study by Bandeira et al. when the total SOD activity and the 
lipid peroxidation were higher in diabetics compared to non-diabetics [54]. Another study 
by Savu et al. also showed increase in anti-oxidant capacity despite high levels of oxidative 
stress [55]. Cabigas et al. have also shown over expression of catalase in myeloid cells 
following acute myocardial infarction [56].
Regarding the role of GAL-3 in IR, Matarrese et al. [41] have reported that GAL-3 
interferes with ROS generation and so might interfere with very early stages of cell death that 
are associated with perturbation of mitochondrial homeostasis and subsequent formation 
of ROS.  They also report that overexpression of GAL-3 protects cells from death through 
inhibition of ROS formation by promoting mitochondrial homeostasis. Mukaru et al. [57], 
have also shown increased GAL-3 is associated with increased GSH level. There is further 
evidence in literature that indicate that GAL-3 is protective in IR injuries e.g. GAL-3 was 
found to be involved in the kidney regeneration [58] and has also shown to play a protective 
role in ischemia reperfusion injury of the liver [59].
Thus the increase in the anti-oxidant activity linked to GAL-3, observed in the present 
study, may suggest two possibilities; either it is the result of a possible adaptive response, 
probably due to the increased production of the oxidative radicals or due to the inherent role 
of GAL-3 in decreasing oxidative stress.
An interesting observation in our study was that the immunohistochemical expression 
of NRF2 positive cells was higher in the GAL-3 wild type mice than in GAL-3 KO mice after 
IR injury.
This shows that GAL-3 caused an increase in the NRF2 expression in the myocardium. 
There have been no reports in literature, to date, showing a direct relationship between GAL-
3 and NRF2, however, NRF2 has been shown to control intracellular ROS levels following IR 
injury in cardiac cell culture [60].  Also in animal experiments, acute activation of NRF2 has 
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been shown to be cardioprotective following IR injury [27, 61]. We can therefore hypothesize 
that GAL-3 confers protection partly through the NRF2 cytoprotective pathway.
IR injury is also associated with influx of inflammatory cells comprising predominantly 
of neutrophil polymorphs. CRP, IL-6, MPO, and neutrophil elastase are reliable markers for 
determining the magnitude of inflammatory response [62, 63]. We show significantly higher 
levels of LV CRP, IL6, MPO, and neutrophil elastase in IR GAL-3 wild group as compared to 
the IR GAL-3 KO group. This observation supports a pro-inflammatory role of GAL-3 in IR 
injury. We have identified that knocking out GAL-3 gene results in a significant decrease in 
LV inflammatory markers as well as a significant increase in LV cell death. This paradox is 
very interesting and suggests multiple roles of GAL-3 in IR injury and that although knocking 
out GAL-3 is associated with lowering inflammatory response, it leads to an increase in cell 
death through increased apoptotic rate and decreased anti-oxidative activity. All these are 
pointing towards a protective role of GAL-3 at 24-hour post IR injury. Although GAL-3‘s role 
as a pro-inflammatory mediator is shown in our work and in previous studies [11, 64], we do 
not have a clear mechanistic understanding as to how this role reconciles with its protective 
role after IR injury.
Conclusion
Our study shows that GAL-3 can affect the redox pathways, controlling cell survival and 
death, and play a protective role on the myocardium following IR injury.
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